Halofuginone: a potent inhibitor of critical steps in angiogenesis progression
暂无分享,去创建一个
A. Nagler | M. Pines | I. Hemo | R. Reich | I. Vlodavsky | H. Miao | M. Elkin | Reuven Reich | Elena Aingorn | Itzhak Hemo | Hong-Liang Dou | Mark Pines | E. Aingorn
[1] S. Badylak,et al. Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold. , 1999, Biomaterials.
[2] S. Ben‐Sasson,et al. Anticancer drug targets: approaching angiogenesis. , 1999, The Journal of clinical investigation.
[3] V. Brower. Tumor angiogenesis—new drugs on the block , 1999, Nature Biotechnology.
[4] M. Neeman,et al. Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis. , 1999, Neoplasia.
[5] A. Hochberg,et al. Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone. , 1999, Cancer research.
[6] A. Hochberg,et al. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] W. Stetler-Stevenson,et al. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. , 1999, The Journal of clinical investigation.
[8] H. Tsuzuki,et al. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. , 1999, Cancer research.
[9] J. Paul Robinson,et al. Small Intestinal Submucosa: A Tissue-Derived Extracellular Matrix That Promotes Tissue-Specific Growth and Differentiation of Cells in Vitro , 1998 .
[10] M. Pines,et al. Halofuginone: a novel antifibrotic therapy. , 1998, General pharmacology.
[11] S. Itohara,et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.
[12] M. Pines,et al. Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone. , 1997, Kidney international.
[13] C. S. Chen,et al. Geometric control of cell life and death. , 1997, Science.
[14] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[15] O. Halevy,et al. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone. , 1996, Biochemical pharmacology.
[16] J. Folkman,et al. A model of angiogenesis in the mouse cornea. , 1996, Investigative ophthalmology & visual science.
[17] W. Risau. Differentiation of endothelium , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] M. Benezra,et al. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[20] H. Schnaper,et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro , 1993, Journal of cellular physiology.
[21] Shant Kumar,et al. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. , 1993, Journal of cell science.
[22] O. Halevy,et al. Halofuginone: an inhibitor of collagen type I synthesis. , 1993, Biochimica et biophysica acta.
[23] D. Ingber. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis , 1991, Journal of cellular biochemistry.
[24] P. Bornstein,et al. Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. , 1991, The Journal of biological chemistry.
[25] M. Pines,et al. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone. , 1991, Poultry science.
[26] M. Iruela-Arispe,et al. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[27] R. Nicosia,et al. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[28] J. Schittny,et al. Molecular architecture of basement membranes , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[30] D. Ingber,et al. Inhibition of angiogenesis through modulation of collagen metabolism. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[31] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[32] Z. Werb,et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.
[33] L. Liotta,et al. Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.
[34] D. Gospodarowicz,et al. Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[36] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[37] S. Badylak,et al. Small intestinal submucosa: a substrate for in vitro cell growth. , 1998, Journal of biomaterials science. Polymer edition.
[38] M. Pines,et al. Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[39] H. Kleinman,et al. Regulation of capillary formation by laminin and other components of the extracellular matrix. , 1997, EXS.
[40] L Santi,et al. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. , 1994, Oncology research.
[41] C. Jackson,et al. Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium. , 1991, Experimental cell research.
[42] D. Gospodarowicz,et al. The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells. , 1980, Journal of supramolecular structure.